News

KYAN Technologies Announces Presentation at the 2023 AACR-KCA Joint Conference on Precision Medicine in Cancer

Presenting combinatorial ex vivo evaluation of 3D patient-derived organoids in colorectal cancer

KYAN Technologies, a clinical-stage, functional precision medicine company, today announced a poster presentation at the 2023 AACR-KCA Joint Conference on Precision Medicine in Cancer to be held in Seoul, Korea from November 15-17, 2023.

Details related to the poster presentation:
Poster Number: P2-062
Abstract Number: AK23_00594
Abstract Title: Harnessing Optim.AI™ and PD3D® models to investigate combinatorial therapies involving MAPK pathway inhibition in colorectal cancer
Session: Poster Session 2 (Friday, November 17th, 2023 from 08:30-17:20 KST)
Place: Lotte Hotel Seoul, Emerald Room (2F)

Share